Skip to main content

Wealthspire Advisors, LLC

SEC CIK
0001646247
Latest filing
Aug 11, 2026

LCTX holding history

Lineage Cell Therapeutics, Inc. in every 13F filed by Wealthspire Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings

Shares (Q2 2026)
80,088
Value
$104.9K
% of portfolio
<0.1%
Quarters held
2
Since Q3 2025
Holdings of LCTX by Wealthspire Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202680,088$104.9K<0.1%+80,088NewHolders
Q4 20250$00.0%−88−100.0%Sold outHolders
Q3 202588$149<0.1%+88NewHolders